C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype

[1]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[2]  C. Patterson,et al.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging , 2007, Neurobiology of Aging.

[3]  A. Hofman,et al.  Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia , 2007, Neurobiology of Aging.

[4]  D. Sparks,et al.  Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease , 2006, Neurological research.

[5]  D. Sparks,et al.  Statin therapy in Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.

[6]  S. Roman,et al.  Heterogeneity of Apolipoprotein E Polymorphism in Different Mexican Populations , 2006, Human biology.

[7]  V. Gudnason,et al.  Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. , 2006, Atherosclerosis.

[8]  P. Ridker,et al.  Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein , 2006, Genes and Immunity.

[9]  T. Lehtimäki,et al.  Apolipoprotein E genotype is related to plasma levels of C‐reactive protein and lipids and to longevity in nonagenarians , 2006, Clinical endocrinology.

[10]  A Hofman,et al.  C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.

[11]  Farzaneh A. Sorond,et al.  Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis , 2005, The Lancet Neurology.

[12]  J. Smit,et al.  Serum inflammatory proteins and cognitive decline in older persons , 2005, Neurology.

[13]  Paul K Crane,et al.  Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics. , 2004, Psychological assessment.

[14]  A. Windemuth,et al.  New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. , 2004, Atherosclerosis.

[15]  W. März,et al.  The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). , 2004, European heart journal.

[16]  T. Strandberg,et al.  Predictors of cognitive decline and mortality of aged people over a 10-year period. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  W. Strittmatter,et al.  APOE genotype-specific differences in human and mouse macrophage nitric oxide production , 2004, Journal of Neuroimmunology.

[18]  S. Rubin,et al.  Inflammatory markers and cognition in well-functioning African-American and white elders , 2003, Neurology.

[19]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[20]  W. Jagust,et al.  Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors , 2003, Journal of the American Geriatrics Society.

[21]  Xinghua Zhou,et al.  Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. , 2001, Immunology.

[22]  Sridevi Devaraj,et al.  Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.

[23]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[24]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[25]  R. Costa,et al.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan , 2001, Neurology.

[26]  F. Massó,et al.  Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. , 2000, Human biology.

[27]  D. Schmechel,et al.  Altered immune responses in apolipoprotein E-deficient mice. , 2000, Journal of lipid research.

[28]  T. D. Du Clos.  Function of C-reactive protein , 2000, Annals of medicine.

[29]  Judith D. Goldberg,et al.  Applied Survival Analysis , 1999, Technometrics.

[30]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[31]  W. Jagust,et al.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. , 1999, JAMA.

[32]  P. Ridker,et al.  Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[33]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[34]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[35]  H. Akaike.  A new look at the statistical model identification , 1974 .